Valaciclovir Prophylaxis Effective in Preventing Herpes Zoster in SLE Patients on Anifrolumab: Study Finds Medha Baranwal27 Jan 2025 8:15 PM ISTFrance: A recent study, published in RMD Open: Rheumatic & Musculoskeletal Diseases has confirmed valaciclovir's efficacy in preventing herpes...
CDSCO Panel Approves AstraZeneca pharma's Protocol Amendment proposal to study Anifrolumab Dr. Divya Colin1 July 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
CDSCO Panel Grants AstraZeneca's Protocol Amendment Proposal for Anifrolumab Dr. Divya Colin4 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation CDSO has approved the drug major's...
Rare case of treatment of cutaneous juvenile dermatomyositis with Anifrolumab: A report Medha Baranwal8 Dec 2023 11:00 PM ISTUSA: A recent case study published in JAMA Dermatology describes the case of rapid improvement in recalcitrant cutaneous juvenile dermatomyositis...
High dose Anifrolumab Effective for Treatment of Lupus Nephritis Jacinthlyn Sylvia26 Sept 2023 9:45 AM ISTA two-year phase II TULIP-LN trial (NCT02547922) demonstrated the safety and efficacy of anifrolumab in treating active lupus nephritis, with the...
Anifrolumab considerably improves outcomes in refractory discoid lupus erythematosus Jacinthlyn Sylvia28 March 2023 9:30 AM ISTA new article published in the Journal of American Medical Association suggests that in a short retrospective research, every patient with discoid...
Conduct CT in Indian population: CDSCO Panel Tells AstraZeneca for Anifrolumab Dr. Divya Colin19 Dec 2022 6:00 PM ISTNew Delhi: Highlighting that the there is no study data available in Indian population for monoclonal antibody Anifrolumab 150mg/ml concentrate for...
Anifrolumab promising for patients with moderate to severe lupus: reveals Longest SLE trial Dr. Kamal Kant Kohli17 Nov 2022 8:00 PM ISTUSA: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement ranging from mild to life-threatening...
Medical Bulletin 14/November/2022 Isra Zaman14 Nov 2022 3:49 PM ISTHere are the top medical news for the day:Probiotic 'backpacks' as a potential treatment for inflammatory bowel diseasesLike elite firefighters headed...
Anifrolumab and deucravacitinib combo shows promise in patients with lupus Isra Zaman14 Nov 2022 9:30 AM ISTType I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease....
AstraZeneca gets CDSCO panel nod to study lupus erythematosus drug Anifroluma Medical Dialogues Team19 Dec 2021 11:15 AM ISTNew Delhi: In a significant development, drug-major AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the...
AstraZeneca Saphnelo gets USFDA nod for treating Systemic Lupus Erythematosus Ruchika Sharma3 Aug 2021 11:15 AM ISTNew Delhi: AstraZeneca has recently announced that the company has received approval in the United States (US) for Saphnelo (anifrolumab-fnia) for the...
